Commonly used drug may prevent fetal alcohol syndrome

February 20, 2006

Fetal alcohol syndrome (FAS) is often called the number one preventable birth defect. Despite counselling of pregnant women to avoid alcohol, large numbers of babies are born with FAS. At present, no effective treatments exist that can prevent or reverse FAS after fetal exposure to alcohol. However, Alessandro Ieraci and Daniel Herrera now report encouraging results in mice that might one day change this situation.

The researchers tested whether nicotinamide, a drug that is commonly used in patients with some autoimmune diseases, could protect mice after alcohol exposure. They injected mouse pups shortly after birth with alcohol (mouse brain development happens a bit later in humans, and the time shortly after birth in mice corresponds to brain development in human babies during the third trimester of pregnancy). They found that this single exposure to alcohol (the levels were comparable to those of a human fetus after one-time excessive drinking by the pregnant mother) caused the death of brain cells in the mouse pups, as well as a range of behavioral abnormalities after the pups had grown into adult mice. When Ieraci and Herrera followed the injection of alcohol with a second injection of nicotinamide 2 hours later, the number of brain cells that died was no greater than during normal brain development, and the mice did not show behavioral abnormalities as adults. A weaker but noticeable protective effect against the cell death in the brain was also seen when nicotinamide was administered up to 8 hours after alcohol exposure.

These are early-stage experiments done in a mouse model of FAS, and much more work is needed before it will become clear whether this treatment would work in humans. That said, the results suggest that nicotinamide might be able to prevent some of the alcohol damage to the baby if the mother takes it soon after drinking alcohol. The emphasis in FAS prevention must obviously remain on helping pregnant women (and women who might become pregnant) to quit drinking alcohol. However, it is worth pursuing nicotinamide as a possible treatment for preventing FAS in situations where a pregnant woman is unable to stop drinking entirely.

All works published in PLoS Medicine are open access. Everything is immediately available without cost to anyone, anywhere--to read, download, redistribute, include in databases, and otherwise use--subject only to the condition that the original authorship is properly attributed. Copyright is retained by the authors. The Public Library of Science uses the Creative Commons Attribution License."

Citation: Ieraci A and Herrera DG (2006) Nicotinamide protects against ethanol-induced apoptotic neurodegeneration in the developing mouse brain. PLoS Med 3(4): e101.




Related image for press use:

Caption: Fluoro-Jade-B staining of dying neurons after ethanol exposure

Daniel G. Herrera
Weill Medical College of Cornell University
1300 York Avenue
New York, NY USA 10021
212-746 5884


Related Alcohol Articles from Brightsurf:

Alcohol use changed right after COVID-19 lockdown
One in four adults reported a change in alcohol use almost immediately after stay-at-home orders were issued: 14% reported drinking more alcohol and reported higher levels of stress and anxiety than those who did not drink and those whose use stayed the same.

Changes in hospitalizations for alcohol use disorder in US
Changes over nearly two decades in the rate of hospitalizations and in-hospital deaths from alcohol use disorder in the US were examined in this study.

Associations of alcohol consumption, alcohol-induced passing out with risk of dementia
The risk of future dementia associated with overall alcohol consumption and alcohol-induced loss of consciousness in a population of current drinkers was examined in this observational study with more than 131,000 adults.

New alcohol genes uncovered
Do you have what is known as problematic alcohol use?

Does estrogen influence alcohol use disorder?
A new study from researchers at the University of Illinois at Chicago shows that high estrogen levels may make alcohol more rewarding to female mice.

Sobering new data on drinking and driving: 15% of US alcohol-related motor vehicle fatalities involve alcohol under the legal limit
A new study in the American Journal of Preventive Medicine, published by Elsevier, found that motor vehicle crashes involving drivers with blood alcohol concentrations (BACs) below the legal limit of 0.08 percent accounted for 15% of alcohol-involved crash deaths in the United States.

Alcohol-induced deaths in US
National vital statistics data from 2000 to 2016 were used to examine how rates of alcohol-induced deaths (defined as those deaths due to alcohol consumption that could be avoided if alcohol weren't involved) have changed in the US and to compare the results by demographic groups including sex, race/ethnicity, age, socioeconomic status and geographic location.

Cuts in alcohol duty linked to 2000 more alcohol-related deaths in England
Government cuts to alcohol taxes have had dramatic consequences for public health, including nearly 2000 more alcohol-related deaths in England since 2012, according to new research from the University of Sheffield's School of Health and Related Research (ScHARR).

Integrated stepped alcohol treatment for people in HIV care improves both HIV & alcohol outcomes
Increasing the intensity of treatment for alcohol use disorder (AUD) over time improves alcohol-related outcomes among people with HIV, according to new clinical research supported by the National Institutes of Health.

The Lancet:Targets to reduce harmful alcohol use are likely to be missed as global alcohol intake increases
Increasing rates of alcohol use suggest that the world is not on track to achieve targets against harmful alcohol use, according to a study of 189 countries' alcohol intake between 1990-2017 and estimated intake up to 2030, published in The Lancet.

Read More: Alcohol News and Alcohol Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to